The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.
暂无分享,去创建一个
[1] H. El‐Serag,et al. Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? , 2003, American Journal of Gastroenterology.
[2] L J Schouten,et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. , 2000, International journal of epidemiology.
[3] H. Welch,et al. Trends in diagnostic testing following a national guideline for evaluation of dyspepsia. , 1996, Archives of internal medicine.
[4] A. Jemal,et al. Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.
[5] M. Blaser,et al. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. , 1999, The Journal of infectious diseases.
[6] Peter H Gann,et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.
[7] H. El‐Serag,et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA , 2002, Gut.
[8] D. Corley,et al. Marked Multi-Ethnic Variation of Esophageal and Gastric Cardia Carcinomas within the United States , 2004, American Journal of Gastroenterology.
[9] J. Faivre,et al. Time trends in diagnostic strategy, treatment, and prognosis of gastric cancer in the elderly: a population based study. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[10] W C Black,et al. Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening. , 2000, Journal of the National Cancer Institute.
[11] J. Lagergren,et al. Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia , 1999, Annals of Internal Medicine.
[12] D. Graham. The changing epidemiology of GERD: geography and Helicobacter pylori , 2003, American Journal of Gastroenterology.
[13] H. El‐Serag. The epidemic of esophageal adenocarcinoma. , 2002, Gastroenterology clinics of North America.
[14] C. Miller,et al. Incidence and Survival Trends of Esophageal Carcinoma in the United States: Racial and Gender Differences by Histological Type , 2002, Scandinavian journal of gastroenterology.
[15] Joseph K McLaughlin,et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. , 2004, Journal of the National Cancer Institute.
[16] R. Hayes,et al. Adenocarcinoma of the esophagus: role of obesity and diet. , 1995, Journal of the National Cancer Institute.
[17] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[18] A. Lindgren,et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.
[19] L. Hansson,et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. , 1999, Journal of the National Cancer Institute.
[20] L. Brown,et al. Epidemiologic trends in esophageal and gastric cancer in the United States. , 2002, Surgical oncology clinics of North America.
[21] N. Day,et al. A case-control study of oesophageal adenocarcinoma in women: a preventable disease , 2000, British Journal of Cancer.
[22] J. Fraumeni,et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.